Rapport Therapeutics, Inc. RAPP Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $52.65M-7.3% | $56.81M-19.0% | $70.17M— | ||
| $437.89M+76.2% | $248.48M+221% | $77.31M— | ||
| —— | —— | —— | ||
| $498.56M+60.9% | $309.8M+105% | $150.87M— | ||
| $2.98M-15.7% | $3.53M+84.2% | $1.92M— | ||
| $512.43M+62.7% | $314.93M+103% | $155.42M— | ||
| $12.74M+217% | $4.02M— | —— | ||
| $19.05M+117% | $8.77M-0.4% | $8.8M— | ||
| $27.78M+192% | $9.51M-34.3% | $14.48M— | ||
| $48K+29.7% | $37K+825% | $4K— | ||
| -$235.23M-90.1% | -$123.75M-172% | -$45.44M— | ||
| $484.65M+58.7% | $305.43M+1,291% | -$25.63M-155% | ||
| $512.43M+62.7% | $314.93M+103% | $155.42M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rapport Therapeutics, Inc.'s total assets?
- Rapport Therapeutics, Inc. (RAPP) holds $497.6M in total assets, up 64.7% year over year.
- How much debt does Rapport Therapeutics, Inc. have?
- Rapport Therapeutics, Inc. carries $10.8M in total debt against $471.5M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Rapport Therapeutics, Inc. have?
- Rapport Therapeutics, Inc. holds $78.1M in cash and equivalents.
- Can Rapport Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 27.08 — current assets exceed current liabilities.
- Where does Rapport Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Rapport Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.